Moleculin Biotech, Inc. (MBRX)
NASDAQ: MBRX · Real-Time Price · USD
0.6499
-0.0388 (-5.63%)
At close: Aug 28, 2026, 4:00 PM EDT
0.6700
+0.0201 (3.09%)
After-hours: Aug 28, 2026, 6:01 PM EDT
Moleculin Biotech Market Cap
Moleculin Biotech has a market cap or net worth of $12.66 million as of August 28, 2026. Its market cap has decreased by -31.20% in one year.
Market Cap
12.66M
Enterprise Value
5.69M
1-Year Change
-31.20%
Ranking
Category
Stock Price
$0.65
ChartMarket Cap Chart
Since June 2, 2016, Moleculin Biotech's market cap has decreased from $70.70M to $12.66M, a decrease of -82.10%. That is a compound annual growth rate of -15.46%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 12.70M | 89.55% |
| Dec 31, 2025 | 6.70M | 31.37% |
| Dec 31, 2024 | 5.10M | -80.08% |
| Dec 29, 2023 | 25.60M | -15.51% |
| Dec 30, 2022 | 30.30M | -43.05% |
| Dec 31, 2021 | 53.20M | 6.83% |
| Dec 31, 2020 | 49.80M | 19.14% |
| Dec 31, 2019 | 41.80M | 48.23% |
| Dec 31, 2018 | 28.20M | -28.24% |
| Dec 29, 2017 | 39.30M | 42.91% |
| Dec 30, 2016 | 27.50M | -61.10% |
| Jun 2, 2016 | 70.70M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Adial Pharmaceuticals | 14.94M |
| AEON Biopharma | 14.66M |
| Moolec Science | 14.56M |
| Intensity Therapeutics | 13.94M |
| Passage Bio | 13.93M |
| SeaStar Medical Holding | 13.66M |
| GT Biopharma | 13.61M |
| BioLineRx | 13.26M |